Curogen
Comprehensive Business Solutions for Licensing, Strategic Advisory, M&A, Due Diligence, Executive Staffing, Capital Raising, and Board of Directors Support
We have decades of Experience
Curogen
We have a successful track record in completing transactions and our global network provide our clients with unbiased and sector-specific advice for their most important strategic decisions as well as access to cutting-edge innovation and attractive global opportunities.
We understand the industry and our clients’ perspectives.
We have decades of senior executive-level management experience at large, mid-size and startup pharma and biotechnology companies.
Your business goals are our priority
At Curogen, our unwavering mission is to empower our clients to attain sustained success within the intricate global landscape.
We achieve this by guiding organizations towards astute strategic choices, facilitating growth through acquisitions, optimizing product licensing, fostering innovation, securing funding, and ensuring the most value-maximizing approach to divestitures.
Why Partner with Curogen?
The life sciences industry has become a fast-changing sector, presenting transformative opportunities for growth. Curogen team have the proven track record and executive experience in assisting you to identify and assess these opportunities to make sure they have the potential of maximizing your return on investment.
Our Track-Record
Supporting our clients in successful deal making and execution with: • our global experience in deal-making • an extensive network of senior contacts and key stakeholders • in-depth industry knowledge Our life science and healthcare clients spanning from global pharma, privately held multinationals, regional and local firms to high growth early stage companies trust us to support their M&A, Licensing, strategic planning and board support activities.
Our Unique Services
We provide strategic insights, business opportunity sourcing, transaction advisory services, negotiation and due diligence support on a global, regional and local basis
Licensing
Whether you are a large global life science player, a small biotech start-up, family-owned company or a regional player in certain region, we have done deals with a firm like yours and Curogen team can help you.
Advisory Services
M&A (divestment’s, mergers, acquisitions, and strategic transactions)
Licensing (in and out licensing)
Strategy (commercialisation, deal strategy, due diligence, market entry
Board Support
Our deep CEO and board-level experience and network of senior executive contacts from innovators, global life science companies, Regulatory authorities, Investment bankers and family offices make us uniquely placed to support the CEO’s and board of directors
Ashraf Allam
Founder & CEO
About the CEO
Ashraf Allam has been recently serving as the CEO of the Pharmaceutical Investment Company (PIC) which is fully owned by the Public Investment Fund (PIF). PIF is a global investment powerhouse and one of the largest sovereign wealth funds in the world, with assets of more than $500 billion. The fund is building a world-class, diversified portfolio through investments in attractive, long-term opportunities at the domestic and international levels. In his capacity, Ashraf was fully responsible for creating, providing, and implementing strategic, financial, and operational leadership for the company, working closely with the senior executive team representing both the shareholders and the board of directors.
Check our top clients & partners
